The largest database of trusted experimental protocols

4 protocols using ccr7 clone g043h7

1

Flow Cytometry Analysis of CAR T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A FACSCanto II (BD Biosciences) instrument was used to acquire flow cytometry data, which was analyzed using FlowJo v10.7 (BD Biosciences). For surface staining, samples were washed with and stained in PBS (Lonza) with 1% FBS (GE Healthcare). For all experiments, matched isotypes or known negatives (e.g. nontransduced T cells or B7-H3-negative cell lines) served as gating controls. CAR detection was performed using F(ab’)2 fragment-specific antibody (polyclonal, Jackson ImmunoResearch, West Grove, PA, USA). T cells were stained with fluorochrome-conjugated antibodies using combinations of the following markers: CD4 (clone SK3, BD Biosciences), CD8 (clone SK1, BD Biosciences), CCR7 (clone G043H7, BioLegend, San Diego, CA, USA), and CD45RO (clone UCHL1, BD Biosciences). LM7 and the negative control leukemia cell line BV173 were evaluated for expression of B7-H3 using B7-H3 antibody (clone 7-517, BD Biosciences, or clone FM276, Miltenyi). Cells were additionally stained with DAPI (BD Biosciences) to gate for live cells.
+ Open protocol
+ Expand
2

Flow Cytometric Analysis of CAR T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A FACSCanto II (BD Biosciences) instrument was used to acquire flow cytometry data, which was analyzed using FlowJo v10 (BD Biosciences). For surface staining, samples were washed with and stained in PBS (Lonza) with 1% FBS (GE Healthcare). For all experiments, matched isotypes or known negatives (e.g., NT T cells) served as gating controls. CAR detection was performed using F(ab′)2 fragment=specific antibody (polyclonal, Jackson ImmunoResearch, West Grove, PA, USA). T cells were stained with fluorochrome-conjugated antibodies using combinations of the following markers: CD4 (clone SK3, BD Biosciences), CD8 (clone SK1, BD Biosciences), CCR7 (clone G043H7, BioLegend, San Diego, CA, USA), CD45RO (clone UCHL1, BD Biosciences), and 41BBL (clone 5F4, BioLegend). Tumor cell lines were evaluated for expression of B7-H3 using B7-H3 antibody (clone 7-517, BD Biosciences, or clone FM276, Miltenyi). To determine apoptosis, T cells were labeled with annexin V (BD Biosciences) and DAPI (BD Biosciences). The percentages of apoptotic cells were determined by the percent annexin V positive.
+ Open protocol
+ Expand
3

Phenotypic Profiling of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
A single-cell suspension of PBMCs was prepared to determine the cellular phenotype by flow cytometry. The following monoclonal antibodies (mAb) were used: CD3 (clone HIT3a), CD4 (clone A161A1), CD25 (clone BC96), TNF (clone MAb11) TNFR1 (clone W15099A), TNFR2 (clone 3G7A02), CD45RA (clone HI100), and CCR7 (clone G043H7), All the mAbs were provided by BioLegend (San Diego, CA, USA). PBMCs were stained for 30 min at 4 °C in the dark.
To determine the intracellular expression of FOXP3, PBMCs were washed, fixed, and permeabilised with the Kit True Nuclear™ Transcription Factor Buffer Set (BioLegend). Then cells were washed twice and stained with mAb to identify FOXP3 (clone 206D). Finally, cells were washed and resuspended in 1% paraformaldehyde.
Cells used for Fluorescence Minus One (FMO) condition were stained and acquired in parallel to identify staining background levels, and dead cells were omitted using Zombie Red™ (BioLegend) viability kit.
The data were collected using a FACS Aria II (BD Biosciences, San Jose, CA, USA) and then analysed by FlowJo v10.2 (FlowJo LLC, Inc, Ashland, OR, USA). In each case, 50,000 events of the live cell's gate were acquired per sample.
+ Open protocol
+ Expand
4

Phenotypic Analysis of Expanded T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells selected and expanded in vitro were characterized using the following fluorochrome-conjugated monoclonal antibodies: APC-conjugated CD3 (clone UCHT1; BioLegend) and CD8+ (clone RPA-T8; BioLegend); FITC-conjugated CD16 (clone 3G8; BioLegend) and CCR7 (clone G043H7; BioLegend); PerCP-Cy5.5-conjugated CD56 (clone B159; BD Biosciences) and CD45RA (clone HI100; BioLegend); BV421-conjugated CD8+ (clone RPA-T8; BD Biosciences); APC-H7-conjugated CD4+ (clone RPA-T4; BD Biosciences); PE-conjugated CD4+ (clone RPA-T4; BioLegend). For the tetramer staining, CTLs were incubated with the PE-conjugated HLA-A*0201-DEPDC1#5 or PE-conjugated HLA-A*0201-Melan-A26–35*A27L tetramers. Samples were analyzed by an LSRII flow cytometer (BD Biosciences) and evaluated with FlowJo software (TreeStar, Inc.).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!